CIK 0001133416 · Non-accelerated filer<br>Smaller reporting company
GALECTIN THERAPEUTICS INC
Sign in to watch- Ticker
- GALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 043562325
- Phone
- 678-620-3186
- Business address
- 4960 PEACHTREE INDUSTRIAL BOULEVARD, SUITE 240, NORCROSS, GA, 30071
- Former names
- PRO PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-17 | Jamil Khurram Chief Medical Officer | Option exercise · Stock option (right to buy) 10b5-1 | −8,500 | 50,000 | ||
| 2025-12-17 | Shlevin Harold H. Director | Option exercise 10b5-1 | +20,000 | $1.98 | $40K | 31,206 |
| 2025-12-17 | Shlevin Harold H. Director | Sale 10b5-1 | −19,793 | $7.04 | $139K | 11,206 |
| 2025-12-17 | Shlevin Harold H. Director | Sale 10b5-1 | −4,706 | $7.04 | $33K | 6,500 |
| 2025-12-17 | Shlevin Harold H. Director | Option exercise · Stock Option (right to buy) 10b5-1 | −20,000 | 0 | ||
| 2025-12-16 | 10X Fund, L.P. 10% owner | Sale | −30,681 | $6.66 | $204K | 5,614,457 |
| 2025-12-15 | Shlevin Harold H. Director | Option exercise 10b5-1 | +8,417 | $4.16 | $35K | 19,623 |
| 2025-12-15 | Shlevin Harold H. Director | Sale 10b5-1 | −8,417 | $6.30 | $53K | 11,206 |
| 2025-12-15 | Shlevin Harold H. Director | Option exercise · Stock option (right to buy) 10b5-1 | −8,417 | 0 | ||
| 2025-12-12 | Shlevin Harold H. Director | Option exercise 10b5-1 | +19,793 | $4.16 | $82K | 30,999 |
| 2025-12-12 | Shlevin Harold H. Director | Sale 10b5-1 | −19,793 | $6.27 | $124K | 11,206 |
| 2025-12-12 | Shlevin Harold H. Director | Option exercise · Stock Option (right to buy) 10b5-1 | −19,793 | 53,417 | ||
| 2025-12-09 | Shlevin Harold H. Director | Option exercise 10b5-1 | +16,790 | $4.16 | $70K | 27,996 |
| 2025-12-09 | Shlevin Harold H. Director | Sale 10b5-1 | −16,790 | $6.27 | $105K | 11,206 |
| 2025-12-09 | Shlevin Harold H. Director | Option exercise · Stock Option (right to buy) 10b5-1 | −16,790 | 73,210 | ||
| 2025-12-08 | Shlevin Harold H. Director | Sale 10b5-1 | −4,000 | $6.01 | $24K | 11,206 |
| 2025-12-08 | Shlevin Harold H. Director | Option exercise 10b5-1 | +35,000 | $2.86 | $100K | 46,206 |
| 2025-12-08 | Shlevin Harold H. Director | Sale 10b5-1 | −35,000 | $5.95 | $208K | 11,206 |
| 2025-12-08 | Shlevin Harold H. Director | Option exercise 10b5-1 | +20,000 | $2.11 | $42K | 31,206 |
| 2025-12-08 | Shlevin Harold H. Director | Sale 10b5-1 | −20,000 | $5.96 | $119K | 11,206 |
Page 5 of 15 · 291 trades